#idose tr

1 story

#business #corneal health #epioxa #glaukos #gross margin #j-code #medicare #money #net sales #nyse

Glaukos Stock: Second J-Code Rewrites Risk Math
Glaukos' second J-code drug launch reshapes risk math for investors.
Seekingalpha · 1m